Global Hydraulic Press Machine Market to Witness 4.8% CAGR during 2017 - 2023     |   Global Auto-Injectors Market to Witness 18.6% CAGR during 2017 – 2023     |    Global Ammonium Phosphate Market to Witness 3.6% CAGR During 2016 – 2022

Toll Free (US/Canada): 1-888-778-7886

INT'L: 1-347-960-6455

enquiry@psmarketresearch.com

P&S Market Research - A market research firm

3D Bioprinting Market

P&S Market Research-3D Bioprinting Market report

Global 3D Bioprinting Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Technology (Syringe Based, Pneumatic Extrusion, Inkjet Based, Laser Based, Others), by Application (Tissue and Organ Regeneration, 3D Cell Culture, Pharmaceutical, Others)

Published: November 2016
Report Code: LS10744
Available Format: pdf
Pages: 108

3D bioprinting refers to the process of creating 3D structures using live cells. The process uses 3D printing technologies for crating live cells or tissue structures. These structures are used for applications in medical or healthcare.  The 3D bioprinted cells or tissues are preserved into the printed construct of different materials. 3D bioprinting has revolutionized the approach towards drug discovery and development. Although, the market is still in nascent form, it is expected to witness significant growth in the coming years. Syringe based technology, pneumatic based technology, inkjet based technology, and the laser based technologies are the major technologies being used for 3D bioprinting. The 3D bioprinting products are being utilized for different applications such as tissue and organ regeneration, stem cell culture and pharmaceutical.

 

The global 3D bioprinting market was valued at $98.6 million in 2015, and it is expected to grow at a CAGR of 35.9% during 2016 - 2022. The increasing demand of tissues and organs for transplantation, increasing research and development activities, the innovations and advancements in technology for 3D bioprinting, and increasing compliance for 3D bioprinting in drug discovery processes are the key factors driving the growth of the global market. The different companies in the market are active in research and development activities to find enhanced solutions for the prevailing demand of regenerative medicine and the increasing need for tissue and organ transplantation. The key players in the market would target their research for the development for tissue engineering to exploit market potential.

The growing stem cell research and increasing adoption of 3D bioprinting in cosmetic industry offer ample opportunities for the growth of global market. As stem cells have potential to develop into different type of cells or tissues, a large number of research and development activities are being carried in academic institutes and research laboratories. Increasing traction for stem cell research would support the growth of the global 3D bioprinting market. The market players in cosmetic industry are collaborating with the 3D bioprinting industry players to develop tissues for cosmetic applications. A large number of collaboration of pharmaceutical or cosmetic industry players with 3D bioprinting industry players might be seen in the coming years. The key challenges faced by the major players in the global market are the high cost of bioprinting and the stringent regulatory processes. Moreover, the dearth of skilled professionals would also hamper the growth of the global market to some extent.

Among the different 3D bioprinting technologies, the syringe based 3D bioprinting generated largest revenue in the global market in 2015. The technology along with pneumatic extrusion based technology accounted for over 60% share in the global market in 2015. The pneumatic extrusion technology is expected to witness the highest growth during the forecast period. In 2015, the 3D bioprinting market for tissue and organ regeneration was largest among all the applications of 3D bioprinting.

North America accounted for the largest share in the global market in 2015 and it is expected to grow at significant rate during the forecast period. The factors driving the 3D bioprinting market in the region are increasing research and development activities and the innovations and advancements in technology. Europe was the second largest market for 3D bioprinting devices in 2015. The European market is primarily driven by increasing compliance for 3D bioprinting in pharmaceutical and cosmetic industries.

The 3D bioprinting market in Asia-Pacific would witness highest growth during the forecast period. The highest growth in the region is attributed to the increasing stem cell research, and increasing developments in China and Japan. China is expected to be the fastest growing market for 3D bioprinting globally during the forecast period.

Some of the major players operating in the global market include Organovo Holdings, Inc., CELLINK, EnvisionTEC, BioBots, Cyfuse Biomedical K.K., Aspect Biosystems Ltd., 3D Bioprinting Solutions, Ourobotics, Advanced Solutions, Inc., GeSiM, Bio3D Technologies, 3Dynamic Systems Ltd., Nano3D Biosciences, Inc., Poietis, regenHU Ltd., and Aerotech Inc.

Chapter 1. Research Scope and Methodology

1.1 Market Definition

1.2 Research Scope

1.2.1 Global 3D bioprinting market breakdown by technology

1.2.2 Global 3D bioprinting market breakdown by application

1.2.3 Global 3D bioprinting market breakdown by geography

1.3 Research Methodology and Sources

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Opportunities in the Global 3D Bioprinting Market

3.2.1 Growing stem cell research

3.2.2 Increasing adoption in cosmetic industry

3.3 Factors Diving the Growth of the Market and its Impact on Market Forecast

3.3.1 Technological advancements and innovations

3.3.2 Increasing compliance for drug discovery processes

3.3.3 High demand for tissues and organs for transplantation

3.3.4 Impact analysis of drivers on market forecast

3.4 Factors Hindering Growth of the Market and its Impact on Market Forecast

3.4.1 High cost of 3D bioprinting

3.4.2 Stringent regulatory requirements

3.4.3 Lack of skilled professionals

3.4.4 Impact analysis of restraints on market forecast

Chapter 4. Global 3D Bioprinting Market Size and Forecast (2012 – 2022)

4.1 Global 3D Bioprinting Market, by Technology

4.2 Global 3D Bioprinting Market, by Application

4.3 Global 3D Bioprinting Market, by Region

Chapter 5. Global 3D Bioprinting Market, by Technology

5.1 Syringe Based 3D Bioprinting Market

5.1.1 Global syringe based 3D bioprinting market, by region

5.2 Pneumatic Extrusion Based 3D Bioprinting Market

5.2.1 Global pneumatic extrusion based 3D bioprinting market, by region

5.3 Inkjet Based 3D Bioprinting Market

5.3.1 Global inkjet based3D bioprinting market, by region

5.4 Laser Based 3D Bioprinting Market

5.4.1 Global laser based 3D bioprinting market, by region

Chapter 6. Global 3D Bioprinting Market, by Application

6.1 3D Bioprinting Market for Tissue & Organ Regeneration

6.1.1 Global 3D bioprinting market for tissue & organ regeneration, by region

6.2 3D Bioprinting Market for 3D Cell Culture

6.2.1 Global 3D bioprinting market for 3D cell culture, by region

6.3 3D Bioprinting Market for Pharmaceutical

6.3.1 Global 3D bioprinting market for pharmaceutical, by region

Chapter 7. Global 3D Bioprinting Market, by Geography

7.1 North America 3D Bioprinting Market

7.1.1 North America 3D bioprinting market, by technology

7.1.2 North America 3D bioprinting market, by application

7.1.3 North America 3D bioprinting market, by country

7.2 Europe 3D Bioprinting Market

7.2.1 Europe 3D bioprinting market, by technology

7.2.2 Europe 3D bioprinting market, by application

7.2.3 Europe 3D bioprinting market, by country

7.3 Asia-Pacific 3D Bioprinting Market

7.3.1 Asia-Pacific 3D bioprinting market, by technology

7.3.2 Asia-Pacific 3D bioprinting market, by application

7.3.3 Asia-Pacific 3D bioprinting market, by country

7.4 Rest of the World (RoW) 3D Bioprinting Market

7.4.1 RoW 3D bioprinting market, by technology

7.4.2 RoW 3D bioprinting market, by application

Chapter 8. Competitive Analysis

8.1 Porters Five Forces of Competitive Position Analysis

8.1.1 Bargaining power of buyers

8.1.2 Bargaining power of suppliers

8.1.3 Threat of new entrants

8.1.4 Intensity of rivalry

8.1.5 Threat of substitutes

8.2 Competitive Positioning of the Global 3D Bioprinting Market, by Technology

Chapter 9. Company Profiles and Strategic Developments

9.1 Key Company Profiles

9.1.1 Organovo Holdings, Inc.

9.1.1.1 Business overview

9.1.1.2 Product and service offerings

9.1.2 CELLINK

9.1.2.1 Business overview

9.1.2.2 Product and service offerings

9.1.3 EnvisionTEC GmbH

9.1.3.1 Business overview

9.1.3.2 Product and service offerings

9.1.4 BioBots, Inc.

9.1.4.1 Business overview

9.1.4.2 Product and service offerings

9.1.5 Cyfuse Biomedical K.K.

9.1.5.1 Business overview

9.1.5.2 Product and service offerings

9.1.6 Aspect Biosystems Ltd.

9.1.6.1 Business overview

9.1.6.2 Product and service offerings

9.1.7 GeSIM

9.1.7.1 Business overview

9.1.7.2 Product and service offerings

9.1.8 regenHU Ltd

9.1.8.1 Business overview

9.1.8.2 Product and service offerings

9.1.9 Nano3D Biosciences, Inc.

9.1.9.1 Business overview

9.1.9.2 Product and service offerings

9.1.10 Aerotech, Inc.

9.1.10.1 Business overview

9.1.10.2 Product and service offerings

9.1.11 Poietis

9.1.11.1 Business overview

9.1.11.2 Product and service offerings

9.1.12 3D Bioprinting Solutions

9.1.12.1 Business overview

9.1.12.2 Product and service offerings

9.1.13 Ourobotics

9.1.13.1 Business overview

9.1.13.2 Product and service offerings

9.1.14 Advanced Solutions, Inc.

9.1.14.1 Business overview

9.1.14.2 Product and service offerings

9.1.15 Bio3D Technologies

9.1.15.1 Business overview

9.1.15.2 Product and service offerings

9.1.16 3Dynamic Systems Ltd

9.1.16.1 Business overview

9.1.16.2 Products and service offerings

9.2 Strategic Developments in the Global 3D Bioprinting Market

Chapter 10. Appendix

10.1 List of Abbreviations  

 

LIST OF TABLES

TABLE 1: SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2: GLOBAL 3D BIOPRINTING MARKET SNAPSHOT

TABLE 3: DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 6: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2016 – 2022)

TABLE 7: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2015)

TABLE 8: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, $M (2016 – 2022)

TABLE 9: GLOBAL 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2015)

TABLE 10: GLOBAL 3D BIOPRINTING MARKET, BY REGION, $M (2016 – 2022)

TABLE 11: GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2015)

TABLE 12: GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET, BY REGION, $M (2016 – 2022)

TABLE 13: GLOBAL PNEUMATIC EXTRUSION BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2015)

TABLE 14: GLOBAL PNEUMATIC EXTRUSION BASED 3D BIOPRINTING MARKET, BY REGION, $M (2016 – 2022)

TABLE 15: GLOBAL INKJET BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2015)

TABLE 16: GLOBAL INKJET BASED 3D BIOPRINTING MARKET, BY REGION, $M (2016 – 2022)

TABLE 17: GLOBAL LASER BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2015)

TABLE 18: GLOBAL LASER BASED 3D BIOPRINTING MARKET, BY REGION, $M (2016 – 2022)

TABLE 19: GLOBAL 3D BIOPRINTING MARKET FOR TISSUE & ORGAN REGENERATION, BY REGION, $M (2012 – 2015)

TABLE 20: GLOBAL 3D BIOPRINTING MARKET FOR TISSUE & ORGAN REGENERATION, BY REGION, $M (2016 – 2022)

TABLE 21: GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, $M (2012 – 2015)

TABLE 22: GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, $M (2016 – 2022)

TABLE 23: GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL, BY REGION, $M (2012 – 2015)

TABLE 24: GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL, BY REGION, $M (2016 – 2022)

TABLE 25: NORTH AMERICA 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 26: NORTH AMERICA 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2016 – 2022)

TABLE 27: NORTH AMERICA 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2015)

TABLE 28: NORTH AMERICA 3D BIOPRINTING MARKET, BY APPLICATION, $M (2016 – 2022)

TABLE 29: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 30: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 31: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 32: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2016 – 2022)

TABLE 33: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2015)

TABLE 34: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, $M (2016 – 2022)

TABLE 35: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 36: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 37: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 38: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2016 – 2022)

TABLE 39: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2015)

TABLE 40: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, $M (2016 – 2022)

TABLE 41: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 42: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 43: ROW 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 44: ROW 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2016 – 2022)

TABLE 45: ROW 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2015)

TABLE 46: ROW 3D BIOPRINTING MARKET, BY APPLICATION, $M (2016 – 2022)

TABLE 47: ORGANOVO HOLDINGS, INC. – KEY FACTS

TABLE 48: CELLINK – KEY FACTS

TABLE 49: ENVISIONTEC GMBH – KEY FACTS

TABLE 50: BIOBOTS, INC. – KEY FACTS

TABLE 51: CYFUSE BIOMEDICAL K.K.– KEY FACTS

TABLE 52: ASPECT BIOSYSTEMS LTD. – KEY FACTS

TABLE 53: GESIM – KEY FACTS

TABLE 54: REGENHU LTD – KEY FACTS

TABLE 55: NANO3D BIOSCIENCES, INC. – KEY FACTS

TABLE 56: AEROTECH, INC. – KEY FACTS

TABLE 57: POIETIS – KEY FACTS

TABLE 58: 3D BIOPRINTING SOLUTIONS – KEY FACTS

TABLE 59: OUROBOTICS – KEY FACTS

TABLE 60: ADVANCED SOLUTIONS, INC. – KEY FACTS

TABLE 61: BIO3D TECHNOLOGIES – KEY FACTS

TABLE 62: 3DYNAMIC SYSTEMS LTD – KEY FACTS

 

LIST OF FIGURES

FIG 1: RESEARCH SCOPE FOR GLOBAL 3D BIOPRINTING MARKET

FIG 2: RESEARCH METHODOLOGY FOR GLOBAL 3D BIOPRINTING MARKET

FIG 3: 3D BIOPRINTING PROCESS

FIG 4: DEVELOPMENT OF BIOINK

FIG 5: GLOBAL 3D BIOPRINTING MARKET, $M (2012 – 2022)

FIG 6: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2022)

FIG 7: GLOBAL 3D BIOPRINTING MARKET SPLIT, BY TECHNOLOGY (2015)

FIG 8: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2022)

FIG 9: GLOBAL 3D BIOPRINTING MARKET SPLIT, BY APPLICATION (2015)

FIG 10: GLOBAL 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2022)

FIG 11: GLOBAL 3D BIOPRINTING MARKET SPLIT, BY REGION (2015)

FIG 12: GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2022)

FIG 13: GLOBAL SYRINGE BASED 3D BIOPRINTING MARKET SPLIT, BY REGION (2015)

FIG 14: GLOBAL PNEUMATIC EXTRUSION BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2022)

FIG 15: GLOBAL PNEUMATIC EXTRUSION BASED 3D BIOPRINTING MARKET SPLIT, BY REGION (2015)

FIG 16: GLOBAL INKJET BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2022)

FIG 17: GLOBAL INKJET BASED 3D BIOPRINTING MARKET SPLIT, BY REGION (2015)

FIG 18: GLOBAL LASER BASED 3D BIOPRINTING MARKET, BY REGION, $M (2012 – 2022)

FIG 19: GLOBAL LASER BASED 3D BIOPRINTING MARKET SPLIT, BY REGION (2015)

FIG 20: GLOBAL 3D BIOPRINTING MARKET FOR TISSUE & ORGAN REGENERATION, BY REGION, $M (2012 – 2022)

FIG 21: GLOBAL 3D BIOPRINTING MARKET FOR TISSUE & ORGAN REGENERATION SPLIT, BY REGION (2015)

FIG 22: GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, $M (2012 – 2022)

FIG 23: GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE SPLIT, BY REGION (2015)

FIG 24: GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL, BY REGION, $M (2012 – 2022)

FIG 25: GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL, BY REGION (2015)

FIG 26: WORLDWIDE MAJOR MARKETS FOR 3D BIOPRINTING (2022)

FIG 27: NORTH AMERICA 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2022)

FIG 28: NORTH AMERICA 3D BIOPRINTING MARKET SPLIT, BY TECHNOLOGY (2015)

FIG 29: NORTH AMERICA 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2022)

FIG 30: NORTH AMERICA 3D BIOPRINTING MARKET SPLIT, BY APPLICATION (2015)

FIG 31: NORTH AMERICA 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2022)

FIG 32: NORTH AMERICA 3D BIOPRINTING MARKET SPLIT, BY COUNTRY (2015)

FIG 33: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2022)

FIG 34: EUROPE 3D BIOPRINTING MARKET SPLIT, BY TECHNOLOGY (2015)

FIG 35: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2022)

FIG 36: EUROPE 3D BIOPRINTING MARKET SPLIT, BY APPLICATION (2015)

FIG 37: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2022)

FIG 38: EUROPE 3D BIOPRINTING MARKET SPLIT, BY COUNTRY (2015)

FIG 39: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2022)

FIG 40: ASIA-PACIFIC 3D BIOPRINTING MARKET SPLIT, BY TECHNOLOGY (2015)

FIG 41: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2022)

FIG 42: ASIA-PACIFIC 3D BIOPRINTING MARKET SPLIT, BY APPLICATION (2015)

FIG 43: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, $M (2012 – 2022)

FIG 44: ASIA-PACIFIC 3D BIOPRINTING MARKET SPLIT, BY COUNTRY (2015)

FIG 45: ROW 3D BIOPRINTING MARKET, BY TECHNOLOGY, $M (2012 – 2022)

FIG 46: ROW 3D BIOPRINTING MARKET SPLIT, BY TECHNOLOGY (2015)

FIG 47: ROW 3D BIOPRINTING MARKET, BY APPLICATION, $M (2012 – 2022)

FIG 48: ROW 3D BIOPRINTING MARKET SPLIT, BY APPLICATION (2015)

FIG 49: ROW FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 50: COMPETITIVE POSITIONING OF THE GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY 

The research offers actual historical market size for the period 2012 – 2015 and market forecast for the period 2016 – 2022 in terms of U.S. dollars.

GLOBAL 3D BIOPRINTING MARKET

  • By Technology
  • By Application
  • By Region

GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY

  • Syringe Based 3D Bioprinting
  • Pneumatic Extrusion Based 3D Bioprinting
  • Inkjet Based 3D Bioprinting
  • Laser Based 3D Bioprinting
  • Others

GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION

  • Tissue and Organ Regeneration
  • 3D Cell Culture
  • Pharmaceutical
  • Others

GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY
North America 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – U.S., and Rest of North America

Europe 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – Germany, France, U.K., and Rest of Europe

Asia-Pacific 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – Japan, China, and Rest of Asia-Pacific

Rest of the World 3D Bioprinting Market

  • By Technology
  • By Application

Please fill the form to get the sample pages.

  

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

$5100
Group License

Group License authorizes access of the publication upto 5 users.

$6100
Site License

Site License authorizes access of the publication to all the employees of the organization at a single geographic location.

$7100
Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.

$9100
down-arrow

Pre-Purchase Enquiry


 

Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Center : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment